LMG Life Sciences Names WilmerHale Life Cycle Firm of the Year and Lisa Pirozzolo General Patent Litigator of the Year

LMG Life Sciences Names WilmerHale Life Cycle Firm of the Year and Lisa Pirozzolo General Patent Litigator of the Year

Firm News

Related Solutions

A global team handling highly complex and sensitive matters in all aspects of litigation.
Providing comprehensive solutions for the acquisition, enforcement and protection of IP.
Clients trust us to protect their most important intellectual property matters.

By patenting their innovations, our clients increase the value of their intellectual property and enhance their ability to compete in the marketplace. We work with laboratory and research teams and R&D and product development groups to determine whether, when and where it is in our clients’ business and technical interests to seek patent protection. And we don’t just file patent applications. Drawing on our experience with patent litigation, corporate financings and technology transactions, we implement IP strategies that conserve resources, add measurable value and give our clients a cost-effective and commercially practical competitive edge.

We help clients obtain more than 750 US and foreign patents each year, covering innovations that span the technological spectrum, including aerospace, biochemistry, biotechnology, business methods, chemistry, computer science, fuel cells, genetics, high-speed data communication, integrated circuits, materials science, medical devices, nanotechnology, pharmaceuticals, semiconductor devices and processes, and software.

We also prepare and prosecute patent applications internationally under the Patent Cooperative Treaty and by working with a network of seasoned patent lawyers around the world. Our experience extends to appeals, interferences and opposition proceedings within the US Patent and Trademark Office, the US Court of Appeals for the Federal Circuit and the European Patent Office.

Intellectual Property Litigation

Lawyers from across the United States and Canada gathered on September 13 at the Essex House in New York to celebrate the annual LMG Life Sciences Awards, recognizing the 2017 top firms and legal professionals in the life sciences industry. WilmerHale was recognized as the Life Cycle Firm of the Year and Partner Lisa Pirozzolo was honored as New England General Patent Litigator of the Year. In addition, the firm was awarded one of five Finance and Transactional Impact Cases of the Year for counseling Editas Medicine in its licensing and collaboration with Allergan—a deal that was led by Partners Steve Barrett and Rosemary Reilly.

LMG Life Sciences, a legal directory guide focusing on US law firms and attorneys who work with life sciences companies, is produced by the Legal Media Group and its editorial structure is divided into categories that cover traditional practice areas that relate to life sciences. Research for the publication was based on interviews and surveys completed by leading lawyers and clients who are active in the market.

In addition to winning three categories, WilmerHale was shortlisted in the following 12 categories:

Finance & Transactional Firm of the Year: Corporate
Finance & Transactional Firm of the Year: Licensing & Collaboration
Venture Capital Firm of the Year
Hatch-Waxman Litigation Firm of the Year: Branded
General Patent Litigation Firm of the Year
Intellectual Property Firm of the Year

Finance & Transactional Attorney of the Year: Corporate
Partner Steven Singer

Finance & Transactional Attorney of the Year: Licensing & Collaboration
Partner Steven Barrett

Hatch-Waxman Litigator of the Year: Branded
Partner Amy Wigmore

General Patent Litigator of the Year: New England
Partner Emily Whelan

General Patent Litigator of the Year: New York
Partner Robert Gunther

US Rising Transactional Star
Partner Cynthia Mazareas

View the full list of LMG Life Sciences award winners.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel